Skip to main content
. 2012 Sep 7;51(40):10054–10059. doi: 10.1002/anie.201204308

Table 1.

Efficacy of the peptides in disrupting the PP1:I2 complex.[a]

Peptide Sequence EC50 [nm]
PDP0 RVTFSEDDEII 87±10
PDP1 RVTFAEAAEII 21±2
PDP2 RVTFAEAAEII 53±8
PDP2m RATAAEAAEII inactive
PDP3 RVTFBpaEAAEII 176±13
PDP3m RATABpaEAAEII inactive

[a] See also Figure S1 in the Supporting Information. The results are presented as the mean±standard error of the mean (n=4). The efficacy of the peptides was determined by an in vitro phosphatase assay, measuring the activity of PP1 toward its 32P-labeled substrate glycogen phosphorylase a.[9]